111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
163.56%
Revenue growth above 1.5x CX's 13.06%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
163.56%
Gross profit growth above 1.5x CX's 23.58%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-340.62%
Negative EBIT growth while CX is at 89.85%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-340.62%
Negative operating income growth while CX is at 70.77%. Joel Greenblatt would press for urgent turnaround measures.
163.81%
Positive net income growth while CX is negative. John Neff might see a big relative performance advantage.
-100.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-100.00%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-100.00%
Share reduction while CX is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-100.00%
Reduced diluted shares while CX is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 10Y revenue/share CAGR while CX stands at 9.37%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative equity/share CAGR over 10 years while CX stands at 52.73%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.